Cargando…
Discovery of primary prostate cancer biomarkers using cross cancer learning
Prostate cancer (PCa), the second leading cause of cancer death in American men, is a relatively slow-growing malignancy with multiple early treatment options. Yet, a significant number of low-risk PCa patients are over-diagnosed and over-treated with significant and long-term quality of life effect...
Autores principales: | Zhou, Kaiyue, Arslanturk, Suzan, Craig, Douglas B., Heath, Elisabeth, Draghici, Sorin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128891/ https://www.ncbi.nlm.nih.gov/pubmed/34001952 http://dx.doi.org/10.1038/s41598-021-89789-x |
Ejemplares similares
-
Integrated Cancer Subtyping using Heterogeneous Genome-Scale Molecular Datasets
por: Arslanturk, Suzan, et al.
Publicado: (2020) -
Integration of Multimodal Data from Disparate Sources for Identifying Disease Subtypes
por: Zhou, Kaiyue, et al.
Publicado: (2022) -
Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies
por: Munj, Seeya Awadhut, et al.
Publicado: (2022) -
Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2019) -
The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer
por: Zhou, Xinchun, et al.
Publicado: (2021)